Table 5 Statistical Reporting in adjusted indirect comparisons [n/N(%)].

From: Epidemiology Characteristics, Methodological Assessment and Reporting of Statistical Analysis of Network Meta-Analyses in the Field of Cancer

Items

n/N

Journal impact factor (n = 37)*

Year of publication (n = 43)#

Low (<5.00) (n = 29)

High (≥5.00) (n = 8)

P-value

Older studies (~2013) (n = 31)

Recent studies (2014~2015) (n = 12)

P-value

Was traditional meta-analysis conducted? (Yes)

42/43(97.67)

28/29(96.55)

8/8(100.00)

0.599

30/31(96.77)

12/12(100.00)

0.534

Were summary measures reported? (Yes)

41/43(97.62)

26/29(89.66)

8/8(100.00)

0.976

29/31(93.55)

12/12(100.00)

0.373

Planned methods of analysis in adjusted indirect comparisons:

 What was the method used?

  Bucher

23/28(82.14)

17/20(85.00)

2/4(50.00)

0.140

15/20(75.00)

8/8(100.00)

0.240

  Other methods

5/28(17.86)

3/20(15.00)

2/4(50.00)

0.123

5/20(25.00)

0/8(0.00)

0.125

  Not reported

15/43(34.88)

9/29(31.03)

4/8(50.00)

0.326

11/31(35.48)

4/12(33.33)

0.896

 Was the method presented or source cited?

  Manuscript

5/23(21.74)

1/16(6.25)

2/4(50.00)

0.033

4/20(20.00)

1/3(33.33)

0.610

  Reference

18/23(78.26)

15/16(93.75)

2/4(50.00)

0.033

16/20(80.00)

2/3(66.67)

0.610

  Not provided

20/43(46.51)

13/29(44.83)

4/8(50.00)

0.798

11/31(35.48)

9/12(75.00)

0.021

 Was handling of multigroup trials reported? (Yes)

2/43(4.65)

0/29(0.00)

1/8(12.50)

0.057

2/31(6.45)

0/12(0.00)

0.373

 Was the similarity assessed?

3/43(6.98)

3/29(10.34)

0/8(0.00)

0.349

3/31(9.68)

0/12(0.00)

0.269

 Was the inconsistency assessed?

  Not reported

36/43(83.72)

25/29(86.21)

5/8(62.50)

0.150

26/31(83.87)

10/12(83.33)

0.970

  Not application

4/7(57.14)

4/4(100.00)

0/3(0.00)

0.050

3/5(60.00)

1/2(50.00)

0.810

  Hypothesis test

3/7(42.86)

0/4(0.00)

3/3(100.00)

0.050

2/5(40.00)

1/2(50.00)

0.810

Additional analyses:

 Was a sensitivity analysis performed?

5/43(11.63)

1/29(3.45)

3/8(37.50)

0.007

3/31(9.68)

2/12(16.67)

0.526

 Was subgroup analysis or meta-regression performed?

9/43(20.93)

8/29(27.59)

1/8(12.50)

0.385

6/31(19.35)

3/12(25.00)

0.827

  1. *6 studies published in journals with no associated impact factor.
  2. #Based on the median division of number of included NMAs, December 31st 2013 is the cut-off point.